Johnson & Johnson
NYSE: JNJ
$154.00
+$2.13 (+1.4%)
Closing Price on November 15, 2024
JNJ Articles
According to Reuters, Bank of America will get a huge financial aid package from the government. Reuters reports that Congress is advancing legislation to release the balance of the TARP funding....
Published:
Last Updated:
According to Reuters, Kuwait canceled a $17 billion joint venture with Dow Chemical (DOW). Reuters reports that Credit Suisse (CS) clients may have lost $926 million on the Madoff scam. Reuters...
Published:
Last Updated:
Generally speaking, we do not like to bring CEOs back from a past "list of CEOs to go." James Tobin of Boston Scientific Corp. (NYSE: BSX) has somehow managed to hang on to his job and continue to...
Published:
Last Updated:
On tonight’s MAD MONEY on CNBC, Jim Cramer called for companies with high cash balances to make acquisitions while competitors are dirt cheap and vulnerable. Yesterday, Cramer called for Pfizer...
Published:
Last Updated:
According to Reuters, JP Morgan (JPM), Bank of America (BAC), and Merrill Lynch (MER) will cut a total of almost 20,000 jobs. Reuters reports that Boeing (BA) will sign a new deal with machinists....
Published:
Last Updated:
If you thought that high-premium buyouts or M&A was dead, that is not the case in at least some opportunities. Mentor Corp. (NYSE: MNT) has just secured a major premium buyout this Monday...
Published:
Last Updated:
According to MarketWatch, shares in Rio Tinto (RTP) dropped 40% after BHP Billiton (BHP) dropped its offer for the company. According to Reuters, Citigroup’s (C) assurances that it did not need...
Published:
Last Updated:
It looks as though not quite all the mergers are dead on the medical tech and biotechnology front. Johnson & Johnson (NYSE: JNJ) announced that it is acquiring Omrix Biopharmaceuticals, Inc....
Published:
Last Updated:
We have outlined the changes we have seen in the holdings of Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK-A) and these were put into groups in alphabetical order from I to S for the quarter...
Published:
Last Updated:
The Massachusetts Department of Public Health funded a study which is showing further evidence to support the use of drug eluting stents over bare metal stents in heart attack patients. This study...
Published:
Last Updated:
These are some of the other non-tech analyst upgrades and downgrades from Wall Street firms this Wednesday morning: Constellation Energy (CEG) Raised to Buy at Jefferies. Denny’s (DENN) Raised to...
Published:
Last Updated:
Johnson & Johnson (NYSE: JNJ) is showing that some companies can get it right despite tough times. The company has beat earnings and is even raising its fiscal 2008 guidance. The consumer...
Published:
Last Updated:
The market needed Johnson & Johnson (JNJ) to come though with big numbers to show that the consumer goods and medical devices markets, which to a large extent depend on consumer healthcare, were...
Published:
Analysts assume third quarter earnings for the companies in the S&P 500 will be bad. But, looking at the number which is the average of all firms in the index is misleading. The market will be...
Published:
Last Updated:
A big up day in the market, say 4% or 5%, is not a rally, at least not any more. The DJIA has proved that it can move 1,000 points from bottom to top or top to bottom in one trading session. If...
Published:
Last Updated: